Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

4.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

588
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
588
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.2K
Obesity01:24

Obesity

357
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
357
Coagulation01:09

Coagulation

4.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.0K
Disorders of Hemostasis01:24

Disorders of Hemostasis

676
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
676

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same author

Phenotypic and Genetic Characteristics of <i>bla</i><sub>IMP-6</sub>-Harboring <i>Enterobacterales</i> Isolates Lacking <i>bla</i><sub>CTX-M-2</sub> in Japan.

International journal of molecular sciences·2026
Same author

Clinical features, pathogenesis, and treatment of anti-MDA5 antibody-positive interstitial lung disease.

Respiratory investigation·2026
Same author

A Functional TNFRSF13B Variant Disrupts B-Cell Enhancer Activity and Increases Susceptibility to EBV-Negative Lymphoma.

Gene·2026
Same author

Global survey of women's awareness of pregnancy- and postpartum-associated venous thromboembolism (World Thrombosis Day 2025).

Research and practice in thrombosis and haemostasis·2026
Same author

Exogenous Lipoid Pneumonia Caused by E-Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case Report.

Clinical case reports·2026
Same journal

Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of Randomized Clinical Trials.

Thrombosis and haemostasis·2026
Same journal

Novel/Recurrent Variants in Pakistani Glanzmann Thrombasthenia and Glanzmann-like bleeding diathesis: Insights from NGS Analysis.

Thrombosis and haemostasis·2026
Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026
Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026
Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026
See all related articles

Related Experiment Video

Updated: May 24, 2025

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

684

Tissue Factor Pathway-Driven Initial Thrombin Generation is Associated with Hypercoagulability in Obesity.

Yuichi Kamikubo1, Satomi Nagaya2, Rina Inoue1

  • 1Thrombo Translational Research Lab Inc., Chuo-ku, Kumamoto, Japan.

Thrombosis and Haemostasis
|March 6, 2025
PubMed
Summary
This summary is machine-generated.

Initial thrombin generation (TG) via the tissue factor (TF) pathway is elevated in obesity. This suggests TF-bearing microvesicles contribute to hypercoagulation, offering a new assessment method.

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

426
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K

Related Experiment Videos

Last Updated: May 24, 2025

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

684
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

426
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K

Area of Science:

  • Biochemistry
  • Hematology
  • Metabolic Diseases

Background:

  • Tissue factor (TF) pathway initiates coagulation and is implicated in obesity-related hypercoagulability.
  • Existing assays lack the sensitivity to measure initial thrombin generation (TG) in obesity.
  • The link between TF pathway-driven initial TG and hypercoagulability in obesity requires further investigation.

Purpose of the Study:

  • To evaluate the association between TF pathway-driven initial TG and hypercoagulability in obesity.
  • To assess initial TG levels in obese mice and overweight humans using a sensitive assay.

Main Methods:

  • Measured initial TG in plasma from obese (TSOD) mice and overweight humans.
  • Induced initial TG by adding TF to plasma and incubating for 3 minutes.
  • Quantified generated FIIa (thrombin) via amidolytic activity using a fluorogenic substrate.

Main Results:

  • Significantly higher initial TG levels were observed in TSOD mice compared to non-obese controls.
  • Elevated initial TG was noted in obese mice and overweight individuals even without exogenous TF, upon addition of procoagulant phospholipids.
  • Increased initial TG, abolished by anti-TF antibody, was found in plasma pellets from obese mice, not supernatant, suggesting TF-bearing microvesicles.

Conclusions:

  • TF pathway-driven initial TG is significantly elevated in obesity.
  • Increased procoagulant TF-bearing microvesicles likely promote initial TG in obesity.
  • Measuring TF pathway-driven initial TG may serve as a valuable biomarker for assessing hypercoagulability in obesity.